Gainers
Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform.
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Evelo Biosciences (NASDAQ:EVLO) with a Overweight rating and announces Price Target of $28.